Search Results 51-60 of 10256 for Atrophy
The purpose of this study is to evaluate the effectiveness of Lu AF82422 on disease progression in patients with Multiple System Atrophy (MSA). Participation ...
Long-Term Follow-Up Study of Risdiplam in Participants With Spinal Muscular Atrophy (SMA) · Overview · Participation eligibility · Participating Mayo Clinic ...
This disease of the heart muscle makes it harder for the heart to pump blood to the rest of the body. Learn the different types and how they're treated.
About this study. To evaluate whether SSRI use is associated with increased survival time and slower disease progression among patients with MSA.
The pituitary gland is a kidney-bean-sized gland at the base of your brain. It is part of the body's system of glands that make hormones, called the endocrine ...
Multiple system atrophy. This uncommon neurological disorder affects many ... Multiple system atrophy causes a movement disorder, such as ataxia or parkinsonism.
The purpose of this study is to compare the effectiveness of BHV-3241 versus placebo in subjects with Multiple System Atrophy. Participation eligibility.
Imaging biomarkers for early multiple system atrophy. Parkinsonism Relat Disord. 2022 Oct; 103:60-68. Epub 2022 Aug 28. View PubMed; Wenning GK, Stankovic I, ...
Learn about this rare disease that affects brain cells. The disease can make it hard to speak, move and think.
Muscle atrophy. Nerves regrow slowly and can take many years to heal after injury. During that time, not using your muscles may cause them to break down ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift now and help create new and better solutions for more than 1.3 million patients who turn to Mayo Clinic each year.